Mail

Australia markets close in 6 hours 6 minutes

ALL ORDS
7,245.80
+22.70(+0.31%)
ASX 200
7,035.30
+20.10(+0.29%)
AUD/USD
0.6622
-0.0028(-0.42%)
OIL
77.72
-0.14(-0.18%)
GOLD
2,065.50
-1.60(-0.08%)
Bitcoin AUD
57,042.57
-151.85(-0.27%)

FEELING THE PINCH?

Beat the cost-of-living squeeze with our pro tips and helpful hacks - sign up now

Firebrick Pharma Limited (FRE.AX)

ASX - ASX Delayed price. Currency in AUD

Add to watchlist

0.0590

+0.0010

(+1.72%)

As of 03:58PM AEDT. Market open.

Currency in AUD

Valuation measures⁴

Market cap (intra-day)	10.40M
Enterprise value	8.04M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	12.09k
Price/book (mrq)	4.20
Enterprise value/revenue	9.69k
Enterprise value/EBITDA	-1.17

Trading information

Stock price history

Beta (5Y monthly)	N/A
52-week change ³	-77.31%
S&P500 52-week change ³	11.64%
52-week high ³	0.3600
52-week low ³	0.0360
50-day moving average ³	0.0470
200-day moving average ³	0.1588

Share statistics

Avg vol (3-month) ³	1.87M
Avg vol (10-day) ³	4.33M
Shares outstanding ⁵	176.25M
Implied shares outstanding ⁶	176.25M
Float ⁸	94.75M
% held by insiders ¹	70.27%
% held by institutions ¹	1.05%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 June 2023
Most-recent quarter (mrq)	30 June 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	-29,941.77%

Management effectiveness

Return on assets (ttm)	-72.06%
Return on equity (ttm)	-126.49%

Income statement

Revenue (ttm)	22.55k
Revenue per share (ttm)	0.00
Quarterly revenue growth (yoy)	-100.00%
Gross profit (ttm)	22.55k
EBITDA	-6.74M
Net income avi to common (ttm)	-6.8M
Diluted EPS (ttm)	-0.0400
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	2.35M
Total cash per share (mrq)	0.01
Total debt (mrq)	N/A
Total debt/equity (mrq)	N/A
Current ratio (mrq)	5.11
Book value per share (mrq)	0.01

Cash flow statement

Operating cash flow (ttm)	-5.78M
Levered free cash flow (ttm)	-3.2M